This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lim, L C
Right arrow Articles by Schell, R F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lim, L C
Right arrow Articles by Schell, R F

 Previous Article  |  Next Article 

Infection and Immunity, July 1994, p. 2825-2833, Vol. 62, No. 7
0019-9567/1994/$04.00+0     DOI:

research-article

Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi.

L C Lim, D M England, B K DuChateau, N J Glowacki, J R Creson, S D Lovrich, S M Callister, D A Jobe, and R F Schell

Wisconsin State Laboratory of Hygiene, Madison 53706.

ABSTRACT

We present the first direct evidence that adverse effects, particularly severe destructive arthritis, can develop in vaccinated hamsters after challenge with Borrelia burgdorferi sensu lato isolates. Hamsters were vaccinated with a whole-cell preparation of Formalin-inactivated B. burgdorferi sensu stricto isolate C-1-11 in adjuvant. A severe destructive arthritis was readily evoked in vaccinated hamsters challenged with the homologous B. burgdorferi sensu stricto isolate C-1-11 before high levels of protective borreliacidal antibody developed. Once high levels of C-1-11 borreliacidal antibody developed, hamsters were protected from homologous challenge and development of arthritis. Vaccinated hamsters, however, still developed severe destructive arthritis when challenged with other isolates of the three genomic groups of B. burgdorferi sensu lato (B. burgdorferi sensu stricto isolate 297, Borrelia garinii isolate LV4, and Borrelia afzelii isolate BV1) despite high levels of C-1-11 specific borreliacidal antibody. Vaccines that contained whole spirochetes in adjuvant induced destructive arthritis, but this effect was not dependent on the isolate of B. burgdorferi sensu lato or the type of adjuvant. These studies demonstrate that caution is necessary when employing whole spirochetes in adjuvant for vaccination to prevent Lyme borreliosis. Additional studies are needed to identify the antigen(s) responsible for the induction and activation of arthritis and to define the immune mechanisms involved.

Infection and Immunity, July 1994, p. 2825-2833, Vol. 62, No. 7
0019-9567/1994/$04.00+0     DOI:




This article has been cited by other articles:

  • Kotloski, N. J., Nardelli, D. T., Peterson, S. H., Torrealba, J. R., Warner, T. F., Callister, S. M., Schell, R. F. (2008). Interleukin-23 Is Required for Development of Arthritis in Mice Vaccinated and Challenged with Borrelia Species. CVI 15: 1199-1207 [Abstract] [Full Text]  
  • Nardelli, D. T., Callister, S. M., Schell, R. F. (2008). Lyme Arthritis: Current Concepts and a Change in Paradigm. CVI 15: 21-34 [Full Text]  
  • Peterson, S. H., Nardelli, D. T., Warner, T. F., Callister, S. M., Torrealba, J. R., Schell, R. F. (2007). Anti-p19 Antibody Treatment Exacerbates Lyme Arthritis and Enhances Borreliacidal Activity. CVI 14: 510-517 [Abstract] [Full Text]  
  • Nardelli, D. T., Warner, T. F., Callister, S. M., Schell, R. F. (2006). Anti-CD25 Antibody Treatment of Mice Vaccinated and Challenged with Borrelia spp. Does Not Exacerbate Arthritis but Inhibits Borreliacidal Antibody Production. CVI 13: 884-891 [Abstract] [Full Text]  
  • Amlong, C. A., Nardelli, D. T., Peterson, S. H., Warner, T. F., Callister, S. M., Schell, R. F. (2006). Anti-Interleukin-15 Prevents Arthritis in Borrelia-Vaccinated and -Infected Mice. CVI 13: 289-296 [Abstract] [Full Text]  
  • Nardelli, D. T., Burchill, M. A., England, D. M., Torrealba, J., Callister, S. M., Schell, R. F. (2004). Association of CD4+ CD25+ T Cells with Prevention of Severe Destructive Arthritis in Borrelia burgdorferi-Vaccinated and Challenged Gamma Interferon-Deficient Mice Treated with Anti-Interleukin-17 Antibody. CVI 11: 1075-1084 [Abstract] [Full Text]  
  • Munson, E. L., DeCoster, D. J., Nardelli, D. T., England, D. M., Callister, S. M., Schell, R. F. (2004). Neutralization of Gamma Interferon Augments Borreliacidal Antibody Production and Severe Destructive Lyme Arthritis in C3H/HeJ Mice. CVI 11: 35-41 [Abstract] [Full Text]  
  • Burchill, M. A., Nardelli, D. T., England, D. M., DeCoster, D. J., Christopherson, J. A., Callister, S. M., Schell, R. F. (2003). Inhibition of Interleukin-17 Prevents the Development of Arthritis in Vaccinated Mice Challenged with Borrelia burgdorferi. Infect. Immun. 71: 3437-3442 [Abstract] [Full Text]  
  • Christopherson, J. A., Munson, E. L., England, D. M., Croke, C. L., Remington, M. C., Molitor, M. L., DeCoster, D. J., Callister, S. M., Schell, R. F. (2003). Destructive Arthritis in Vaccinated Interferon Gamma-Deficient Mice Challenged with Borrelia burgdorferi: Modulation by Tumor Necrosis Factor Alpha. CVI 10: 44-52 [Abstract] [Full Text]  
  • Munson, E. L., Du Chateau, B. K., Jensen, J. R., Callister, S. M., DeCoster, D. J., Schell, R. F. (2002). Gamma Interferon Inhibits Production of Anti-OspA Borreliacidal Antibody In Vitro. CVI 9: 1095-1101 [Abstract] [Full Text]  
  • Taubman, M.A., Kawai, T. (2001). Involvement of T-Lymphocytes in Periodontal Disease and in Direct and Indirect Induction of Bone Resorption. CROBM 12: 125-135 [Abstract] [Full Text]  
  • Parenti, D. L., Schell, R. F., Callister, S. M., Lovrich, S. D. (2000). Outer Surface Protein A and Arthritis in Hamsters. Infect. Immun. 68: 7212-7213 [Full Text]  
  • Munson, E. L., Du Chateau, B. K., Jobe, D. A., Lovrich, S. D., Callister, S. M., Schell, R. F. (2000). Production of Borreliacidal Antibody to Outer Surface Protein A In Vitro and Modulation by Interleukin-4. Infect. Immun. 68: 5496-5501 [Abstract] [Full Text]  
  • Croke, C. L., Munson, E. L., Lovrich, S. D., Christopherson, J. A., Remington, M. C., England, D. M., Callister, S. M., Schell, R. F. (2000). Occurrence of Severe Destructive Lyme Arthritis in Hamsters Vaccinated with Outer Surface Protein A and Challenged with Borrelia burgdorferi. Infect. Immun. 68: 658-663 [Abstract] [Full Text]  
  • Di Genaro, M. S., Munoz, E., Aguilera, C., de Guzman, A. M. S. (2000). Yersinia enterocolitica O:8 and O:5 lipopolysaccharide arthritogenicity in hamsters. Rheumatology (Oxford) 39: 73-78 [Abstract] [Full Text]  
  • Jensen, J. R., Du Chateau, B. K., Munson, E. L., Callister, S. M., Schell, R. F. (1998). Inhibition of the Production of Anti-OspA Borreliacidal Antibody with T Cells from Hamsters Vaccinated against Borrelia burgdorferi. Infect. Immun. 66: 1507-1512 [Abstract] [Full Text]  
  • Straubinger, R. K., Straubinger, A. F., Summers, B. A., Erb, H. N., Harter, L., Appel, M. J. G. (1998). Borrelia burgdorferi Induces the Production and Release of Proinflammatory Cytokines in Canine Synovial Explant Cultures. Infect. Immun. 66: 247-258 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»